Literature DB >> 27718287

Obstetrical management of patients with extra-anatomic vascular bypass grafts due to Takayasu arteritis.

Naoyuki Miyasaka1, Makiko Egawa1, Mitsuaki Isobe2, Yoshinori Inoue3, Toshiro Kubota1.   

Abstract

Little is known about the obstetrical management of patients with Takayasu arteritis (TA) who have undergone extra-anatomic vascular bypass (EAVB). We describe two cases of EAVB. Case 1 underwent EAVB due to renovascular hypertension associated with stenosis of the abdominal aorta, and Case 2 due to amaurosis fugax episodes associated with stenosis of the brachiocephalic and left common carotid arteries. Pregnancy outcomes were favorable for both cases, though the original symptoms recurred during the third trimester in each case, possibly due to increased blood flow to the pregnant uterus. Neither bypass occlusion nor anastomotic aneurysm formation was observed. Pregnancy outcomes of patients with EAVB due to TA are favorable, although pregnancies of patients with TA who have cardiovascular complications are associated with an increased risk of maternal and fetal morbidity. The obstetrical management of these patients, however, should include monitoring for complications related to the EAVB.
© 2016 Japan Society of Obstetrics and Gynecology.

Entities:  

Keywords:  Takayasu disease; anticoagulation; complications; extra-anatomic bypass graft; pregnancy

Mesh:

Year:  2016        PMID: 27718287     DOI: 10.1111/jog.13139

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  2 in total

Review 1.  Optical techniques for cervical neoplasia detection.

Authors:  Tatiana Novikova
Journal:  Beilstein J Nanotechnol       Date:  2017-09-06       Impact factor: 3.649

2.  When the Uterus Competes for Perfusion: Management of a Pregnant Patient with Bypass Graft Occlusion.

Authors:  Sarah McGriff; Paige Percer; Iberia Sosa; Hector Mendez-Figueroa; Joseph L Mills; Manisha Gandhi
Journal:  Case Rep Obstet Gynecol       Date:  2019-10-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.